Trial of the Immunogenicity, Safety, and Tolerability of rF1V Vaccine With CpG 1018® Adjuvant Compared With rF1V Vaccine in Adults 18 to 55 Years of Age

Name: Trial of the Immunogenicity, Safety, and Tolerability of rF1V Vaccine With CpG 1018® Adjuvant Compared With rF1V Vaccine in Adults 18 to 55 Years of Age
License: Public Domain

Dynavax Technologies Corporation

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

plague

plague, pneumonic, plague, vaccine-preventable diseases

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 226358
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.